Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette E Fleckenstein

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 4, 2011
Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometryPaula L Vieira-Brock, Eleanor I Miller, Shannon M Nielsen, et al.
Journal of Neurochemistry|July 24, 2010
Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine releasePei-Wen Chu, Gregory C Hadlock, Paula Vieira-Brock, et al.
Drug and Alcohol Dependence|December 7, 2014
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessmentKaren Curtin, Annette E Fleckenstein, Reid J Robison, et al.
Drug and Alcohol Dependence|June 18, 2026
Methcathinone self-administration decreases dopamine and serotonin transporter function in ratsCharlotte P Magee, Kathleen Nguyen, BaoMinh D Le, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2007
Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesiclesTrent J Volz, Sarah J Farnsworth, Jill L King, et al.
Journal of Neurochemistry|July 28, 2021
Methcathinone decreases dopamine transporter function: Role of protein kinase CCharlotte P Magee, BaoMinh D Le, Yasmeen H Siripathane, et al.
The International Journal of Neuropsychopharmacology|July 13, 2015
Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition DeficitsPaula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2010
Effect of methamphetamine self-administration on neurotensin systems of the basal gangliaPaul S Frankel, Amanda J Hoonakker, Mario E Alburges, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2018
Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorderKaren Curtin, Annette E Fleckenstein, Brooks R Keeshin, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 4, 2011
Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometryPaula L Vieira-Brock, Eleanor I Miller, Shannon M Nielsen, et al.
Journal of Neurochemistry|July 24, 2010
Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine releasePei-Wen Chu, Gregory C Hadlock, Paula Vieira-Brock, et al.
Drug and Alcohol Dependence|December 7, 2014
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessmentKaren Curtin, Annette E Fleckenstein, Reid J Robison, et al.
Drug and Alcohol Dependence|June 18, 2026
Methcathinone self-administration decreases dopamine and serotonin transporter function in ratsCharlotte P Magee, Kathleen Nguyen, BaoMinh D Le, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2007
Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesiclesTrent J Volz, Sarah J Farnsworth, Jill L King, et al.
Journal of Neurochemistry|July 28, 2021
Methcathinone decreases dopamine transporter function: Role of protein kinase CCharlotte P Magee, BaoMinh D Le, Yasmeen H Siripathane, et al.
The International Journal of Neuropsychopharmacology|July 13, 2015
Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition DeficitsPaula L Vieira-Brock, Lisa M McFadden, Shannon M Nielsen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicityJ Paul Hansen, Evan L Riddle, Verónica Sandoval, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2010
Effect of methamphetamine self-administration on neurotensin systems of the basal gangliaPaul S Frankel, Amanda J Hoonakker, Mario E Alburges, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2018
Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorderKaren Curtin, Annette E Fleckenstein, Brooks R Keeshin, et al.
Pageof 8